VALIULLINA, Z.R.,
GALEEVA, A.M.,
GIMALOVA, F.A.,
SELEZNEVA, N.K.,
KHASANOVA, L.S.,
MIFTAKHOV, M.S.,
MAVZYUTOV, A.R (2019) . The compounds that have been found exceed in their activity the known
drugs Meropenem and Cilapenem.
LEGG, L.A.,
TILNEY, R.,
HSIEH, C.F.,
WU, S.,
LUNDSTRÖM, E.,
RUDBERG, A.S.,
KUTLUBAEV, M.A.,
DENNIS, M.,
MEAD, G.E.,
SOLEIMANI, B.,
BARUGH, A.,
HACKETT, M.L.,
HANKEY, G.J (2019) excluded
drugs with mixed pharmacological effects. The comparator was usual care or placebo. To be included
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) . The tested compound is comparable, in terms of its activity to the hepatoprotective
drug SAM according